D-0900-2023 Class II Terminated
FDA drug recall D-0900-2023 was initiated by L. Perrigo Company on Feb 9, 2023 and is designated Class II. Reason for recall: Failed Impurities/Degradation Specifications The recall status is terminated (terminated Sep 11, 2023). Affected quantity: 11,904 cartons.
Recall Details
- Product Type
- Drugs
- Report Date
- Jul 19, 2023
- Initiation Date
- Feb 9, 2023
- Termination Date
- Sep 11, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 11,904 cartons
Product Description
Allergy, Fexofenadine Hydrochloride Tablets, 180 mg, packaged in a) 30-count cartons (NDC 72288-847-39), and b)150-count cartons (NDC 72288-847-47 and 72288-847-37), Distributed By: Amazon.com Services LLC., 410 Terry Avenue N., Seattle, WA 98109.
Reason for Recall
Failed Impurities/Degradation Specifications
Distribution Pattern
Nationwide within the USA
Code Information
Lot # a) 2GR0329, Exp. date 04/24 Lot # b) 2DR0472, Exp. date 02/23; 2MR0417, Exp. date 07/24
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0900-2023
- openFDA file date
- Nov 3, 2026
- Loaded by RegDataLab
- Nov 4, 2026